Comparative therapeutic efficiency of remdesivir in COVID in a tertiary care center

Comparative therapeutic efficiency of remdesivir in COVID in a tertiary care center

Introduction: The catastrophic effects of corona in 2020 identified the use of broad-spectrum antiviral remdesivir (RDV). The beneficial effects of RDV are not proven and documented in many trials in COVID. Materials and Methods: Reverse transcriptase–polymerase chain reaction (RT-PCR)-confirmed coh...

Full description

Bibliographic Details
Main Authors: Mahendra Munirathnam, R Kishore, S N Sanjana, R Archita, C N Mohan, Preethi Rajeshwari Gandhi, Manjushree Mohan, Bhahuddin Mulla
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:APIK Journal of Internal Medicine
Subjects:
covid
hypoxia
remdesivir
Online Access:http://www.ajim.in/article.asp?issn=2666-1802;year=2021;volume=9;issue=4;spage=244;epage=249;aulast=Munirathnam

Internet

http://www.ajim.in/article.asp?issn=2666-1802;year=2021;volume=9;issue=4;spage=244;epage=249;aulast=Munirathnam

Similar Items